Overview
Hemangiomas of the oral cavity are rare vascular lesions that predominantly affect soft tissues but can also involve bony structures within the oral and maxillofacial region. These lesions are typically benign but can present with significant clinical symptoms such as bleeding, swelling, and aesthetic deformities. The rarity and varied presentations of these lesions necessitate a thorough understanding of their epidemiology, clinical features, diagnostic approaches, and management strategies. This guideline synthesizes evidence from several case series and studies to provide clinicians with a comprehensive overview for managing patients with hemangiomas in the oral cavity.
Epidemiology
Hemangiomas affecting the oral cavity, particularly those involving bony structures, are exceedingly rare. A retrospective study encompassing a small cohort of seven patients underscores this rarity [PMID:16772943]. Despite the limited sample size, the study highlights the sporadic nature of these occurrences. Additionally, clinical presentations observed across different studies suggest a broad age range, with cases reported from pediatric patients to adults. For instance, one study included patients aged between 18 and 71 years, with a mean age of 44 years, comprising 8 men and 7 women [PMID:23660343]. This variability in age and gender distribution indicates that hemangiomas can affect individuals across different demographics, though specific risk factors remain poorly defined due to the scarcity of large-scale epidemiological studies.
In veterinary contexts, similar lesions have been noted, such as a 6-month-old Bassett Hound presenting with recurrent oral bleeding and maxillary swelling, emphasizing the clinical significance of these symptoms in both human and animal patients [PMID:21322431]. These observations suggest that recurrent bleeding and localized swelling should prompt consideration of vascular lesions, including hemangiomas, in the differential diagnosis.
Clinical Presentation
The clinical presentation of hemangiomas in the oral cavity can vary widely depending on the location and extent of the lesion. Studies have documented lesions in diverse facial bone locations, including orbital bones (three cases), mandible (two cases), frontal bone (one case), and zygoma (one case) [PMID:16772943]. These varied anatomical sites highlight the potential for hemangiomas to affect multiple regions within the oral and maxillofacial complex.
Symptoms often include localized swelling, pain, and recurrent bleeding, as exemplified by a canine case where a Bassett Hound presented with recurrent oral bleeding and a palpable mass in the maxillary region [PMID:21322431]. In human patients, the clinical manifestations can be subtle or overt, ranging from asymptomatic masses to more symptomatic presentations that significantly impact quality of life. Age-related differences in presentation are also notable; pediatric cases might present with more acute symptoms due to rapid growth and vascular proliferation, whereas adult cases may present with chronic symptoms related to aesthetic concerns or functional impairment.
Diagnosis
Diagnosing hemangiomas in the oral cavity requires a multi-modal approach given the rarity and varied presentations of these lesions. Initial clinical assessments often guide further diagnostic evaluations. Studies indicate that definitive diagnosis frequently relies on imaging modalities such as Doppler ultrasound and magnetic resonance imaging (MRI) [PMID:23660343]. These imaging techniques help delineate the extent of the lesion and differentiate it from other vascular or neoplastic conditions based on characteristic vascular patterns and tissue characteristics.
However, definitive diagnosis can sometimes be challenging and may require histopathologic assessment, especially when initial biopsies yield inconclusive results. A case report described a scenario where initial biopsies suggested reactive bone changes, leading to empirical treatment without resolution, ultimately necessitating a post-mortem histopathologic diagnosis of maxillary hemangioma [PMID:21322431]. This underscores the importance of maintaining a high index of suspicion and considering advanced diagnostic modalities when clinical suspicion remains high despite initial negative findings.
Management
The management of hemangiomas in the oral cavity is tailored to the specific clinical scenario, including symptom severity, lesion location, and patient preferences. Several treatment modalities have been described, each with varying outcomes and potential complications.
Complications
Despite advancements in treatment modalities, complications can arise from both conservative and interventional approaches. Minor complications include superficial necrosis, which, as reported in one study, healed satisfactorily without long-term sequelae [PMID:23660343]. More significant concerns revolve around recurrence, particularly after partial resections, where two out of five patients experienced tumor recurrence necessitating further extensive surgical interventions [PMID:16772943]. These findings underscore the importance of meticulous surgical technique and close post-operative monitoring to mitigate recurrence risks.
Prognosis & Follow-up
The prognosis for patients with hemangiomas of the oral cavity varies based on the extent of the lesion and the efficacy of the chosen treatment modality. Follow-up evaluations typically span several months to years to assess treatment outcomes and recurrence rates. Studies indicate sustained improvement in most patients post-treatment, with one notable relapse observed in a series of patients followed up at 1, 6, and 12 months [PMID:23660343]. In cases where complete tumor resections were performed, either initially or secondarily following recurrence, no further recurrences were noted over a mean follow-up period of 3 years and 9 months [PMID:16772943]. Regular follow-up is crucial for early detection of any recurrence or complications, ensuring timely intervention and maintaining optimal patient outcomes.
Key Recommendations
References
1 Górriz-Gómez E, Vicente-Barrero M, Loras-Caballero ML, Bocanegra-Pérez S, Castellano-Navarro JM, Pérez-Plasencia D et al.. Sclerotherapy of face and oral cavity low flow vascular malformations: our experience. The British journal of oral & maxillofacial surgery 2014. link 2 Hansen D, Goldstein G, Crews L, Snyder L, Speltz MC. Intraosseous maxillary hemangioma in an immature Bassett Hound. Journal of veterinary dentistry 2010. link 3 Cheng NC, Lai DM, Hsie MH, Liao SL, Chen YB. Intraosseous hemangiomas of the facial bone. Plastic and reconstructive surgery 2006. link